Table 2:

Univariable logistic regression model for overall graft loss, overall mortality and death-censored graft loss in the entire cohort and subgroups by donor type.

	All			Deceased			Living
Variables	OR	95% CI	P-value	OR	95% CI	P-value	OR	95% CI	P-value
Overall graft loss
Age at PKT	1.051	1.041– 1.061	<.0001	1.065	1.052– 1.078	<.0001	1.007	0.990– 1.024	.437
Sex	0.967	0.751– 1.245	.792	0.850	0.631– 1.144	.283	1.075	0.656– 1.762	.773
BMI at PKT	1.037	1.009– 1.066	.009	1.038	1.005– 1.071	.022	0.998	0.944– 1.056	.949
CKD baseline disease 2	1.282	0.754– 2.179	.358	1.319	0.676– 2.574	.418	1.322	0.547– 3.196	.535
CKD baseline disease 3	1.065	0.714– 1.590	.757	1.138	0.701– 1.847	.6	0.900	0.435– 1.860	.776
CKD baseline disease 4	3.042	1.844– 5.020	<.0001	2.398	1.297– 4.432	.005	4.375	1.837– 10.422	.0009
CKD baseline disease 5	3.155	2.008– 4.958	<.0001	3.217	1.907– 5.426	<.0001	1.690	0.589– 4.852	.323
CKD baseline disease 6	1.421	0.928– 2.177	.106	1.296	0.763– 2.203	.338	1.653	0.802– 3.406	.173
CKD baseline disease 7	1.988	1.307– 3.026	.001	2.232	1.368– 3.639	.001	0.902	0.343– 2.371	.834
Cardiovascular disease (ref 0)	2.076	1.464– 2.943	<.0001	2.134	1.436– 3.173	.0002	0.740	0.326– 1.677	.471
Diabetes mellitus (ref 0)	2.027	1.472– 2.792	<.0001	1.867	1.289– 2.704	.001	1.950	1.009– 3.768	.047
Time on waiting list	1.008	1.001– 1.015	.02	1.004	0.995– 1.012	.394	1.008	0.989– 1.026	.409
Donor type (ref 0)	0.434	0.330–0.572	<.0001
Donor age	1.053	1.043–1.063	<.0001	1.051	1.040–1.062	<.0001	1.030	1.007–1.053	.009
Donor height	0.258	0.098–0.681	.006	0.084	0.023–0.300	.001	0.796	0.115–5.526	.817
Donor weight	0.999	0.992–1.007	.881	0.996	0.987–1.005	.356	1.003	0.988–1.018	.72
Donor BMI	0.999	0.991–1.007	.792	1.018	0.991–1.046	.2	0.997	0.983–1.011	.669
Donor COD 2 (ref 1)				1.740	1.186–2.555	.005
Donor COD 3				1.060	0.623–1.805	.829
Donor COD 4				0.821	0.183–3.689	.7964
Donor HT (ref 0)				2.353	1.732–3.197	<.0001
Donor DM (ref 0)				1.272	0.768–2.107	.3498
CIT	1.036	1.020–1.052	<.0001	0.997	0.972–1.022	.798	1.320	1.119–1.557	.001
cPRA	0.997	0.993–1.002	.231	0.997	0.991–1.002	.208	0.997	0.987–1.007	.525
MM A 1 (ref 0)	1.013	0.712–1.443	.942	0.869	0.554–1.364	.542	0.985	0.546–1.778	.959
MM A 2	1.272	0.877–1.844	.205	0.994	0.625–1.579	.979	1.146	0.579–2.269	.696
MM B 1 (ref 0)	1.158	0.750–1.789	.508	0.855	0.495–1.478	.575	1.535	0.729–3.233	.259
MM B 2	1.505	0.981–2.309	.061	1.060	0.624–1.800	.831	1.520	0.695–3.326	.295
MM DR 1 (ref 0)	0.867	0.647–1.160	.334	1.068	0.762–1.498	.702	0.731	0.402–1.329	.304
MM DR 2	1.841	1.330–2.547	.0002	2.513	1.703–3.708	<.0001	1.470	0.777–2.782	.236
Age difference	0.990	0.980–1.000	.045	0.976	0.961–0.991	.003	0.990	0.974–1.006	.203
UBI	1.009	0.997–1.020	.132	1.020	1.006–1.034	.005	0.987	0.969–1.005	.16
eGFR at PKT	1.007	0.976–1.039	.659	1.005	0.968–1.042	.806	1.031	0.972–1.094	.312
Overall mortality
Age at PKT	1.110	1.091	1.128	<0.0001	1.097	1.077	1.117	<0.0001	1.125
Sex	0.793	0.565–1.113	.18	0.778	0.537–1.128	.186	0.438	0.165–1.164	.098
BMI at PKT	1.054	1.018–1.091	.003	1.031	0.991–1.072	.129	1.092	1.004–1.188	.039
CKD baseline disease 2	0.727	0.311–1.697	.461	1.033	0.425–2.509	.943	<0.001	<0.001–>999.999	.967
CKD baseline disease 3	0.870	0.499–1.518	.624	0.878	0.466–1.654	.686	0.801	0.241–2.658	.717
CKD baseline disease 4	4.444	2.468–8.002	<.0001	3.070	1.523–6.188	.002	9.185	3.013–28.003	<.0001
CKD baseline disease 5	3.380	1.915–5.965	<.0001	3.099	1.655–5.803	.0004	1.759	0.344–8.981	.497
CKD baseline disease 6	1.255	0.704–2.240	.441	1.208	0.621–2.350	.578	1.333	0.400–4.443	.639
CKD baseline disease 7	2.221	1.299–3.796	.004	2.277	1.259–4.120	.007	0.803	0.159–4.042	.789
Cardiovascular disease (ref 0)	3.003	2.005–4.497	<.0001	2.850	1.827–4.446	<.0001	2.232	0.752–6.624	.148
Diabetes mellitus (ref 0)	2.479	1.680–3.657	<.0001	1.939	1.247–3.013	.003	4.172	1.782–9.766	.001
Time on waiting list	1.000	0.990–1.011	.959	0.993	0.982–1.005	.26	0.995	0.959–1.032	.776
Donor type (ref 0)	0.267	0.176–0.405	<.0001
Donor age	1.078	1.064–1.092	<.0001	1.066	1.051–1.081	<.0001	1.076	1.034–1.119	.0003
Donor height	0.267	0.080–0.893	.03	0.142	0.032–0.631	.01	0.248	0.024–2.533	.239
Donor weight	0.997	0.987–1.007	.599	0.995	0.985–1.006	.389	0.991	0.964–1.019	.511
Donor BMI	0.998	0.986–1.010	.758	1.010	0.976–1.044	.573	0.995	0.966–1.026	.763
Donor COD 2 (ref 1)				1.677	1.044–2.695	.03
Donor COD 3				1.057	0.547–2.044	.868
Donor COD 4				<0.001	<0.001–>999.999	.986
Donor HT (ref 0)				2.155	1.480–3.137	<.0001
Donor DM (ref 0)				1.034	0.537–1.991	.919
CIT	1.050	1.030–1.070	<.0001	0.994	0.964–1.026	.722	1.343	1.043–1.729	.02
cPRA	0.995	0.988–1.001	.109	0.994	0.987–1.001	.07	0.997	0.982–1.013	.728
MM A 1 (ref 0)	1.574	0.935–2.652	.09	1.100	0.622–1.947	.743	3.206	0.727–14.138	.129
MM A 2	1.823	1.058–3.141	.03	0.997	0.549–1.809	.991	5.820	1.275–26.575	.02
MM B 1 (ref 0)	1.505	0.781–2.901	.222	1.110	0.528–2.334	.784	2.327	0.523–10.348	.267
MM B 2	2.352	1.239–4.464	.009	1.482	0.721–3.045	.284	3.148	0.696–14.234	.1236
MM DR 1 (ref 0)	0.899	0.609–1.328	.593	1.091	0.716–1.662	.687	1.124	0.354–3.570	.843
MM DR 2	2.018	1.329–3.065	.001	2.414	1.507–3.869	.0002	3.461	1.110–10.792	.03
Age difference	1.010	0.996–1.024	.156	0.985	0.966–1.004	.119	1.050	1.019–1.081	.001
UBI	1.017	1.001–1.033	.03	1.020	1.003–1.037	.02	1.013	0.976–1.051	.495
eGFR at PKT	1.016	0.976–1.058	.447	1.026	0.982–1.073	.249	1.004	0.911–1.106	.939
DCGL
Age at PKT	1.001	0.989–1.013	.861	1.020	1.004–1.036	.01	0.961	0.941–0.981	.0002
Sex	1.219	0.855–1.738	.275	1.000	0.640–1.562	.999	1.641	0.913–2.951	.098
BMI at PKT	1.010	0.971–1.051	.613	1.040	0.992–1.090	.104	0.939	0.872–1.011	.094
CKD baseline disease 2	1.924	0.983–3.768	.056	1.716	0.665–4.431	.265	2.169	0.830–5.668	.114
CKD baseline disease 3	1.290	0.742–2.241	.366	1.536	0.755–3.124	.236	0.964	0.394–2.358	.947
CKD baseline disease 4	1.123	0.448–2.818	.804	1.088	0.346–3.427	.885	1.162	0.246–5.491	.849
CKD baseline disease 5	2.307	1.190–4.473	.013	2.522	1.135–5.604	.023	1.591	0.422–6.005	.493
CKD baseline disease 6	1.557	0.860–2.819	.144	1.380	0.617–3.088	.433	1.801	0.747–4.344	.19
CKD baseline disease 7	1.542	0.826–2.880	.174	1.809	0.841–3.888	.129	0.966	0.296–3.153	.955
CVD (ref 0)	0.963	0.523–1.772	.903	0.966	0.473–1.970	.924	0.859	0.260–2.836	.803
Diabetes mellitus (ref 0)	1.333	0.814–2.185	.254	1.497	0.846–2.646	.166	0.878	0.308–2.504	.808
Time on waiting list	1.014	1.005–1.023	.002	1.014	1.003–1.024	.008	1.013	0.992–1.034	.216
Donor type (ref 0)	0.767	0.533–1.104	.153
Donor age	1.021	1.009–1.033	.0004	1.023	1.010–1.037	.0006	1.005	0.979–1.032	.695
Donor height	0.330	0.086–1.266	.106	0.089	0.016–0.497	.006	2.492	0.144–43.184	.53
Donor weight	1.002	0.991–1.013	.719	0.998	0.985–1.011	.734	1.008	0.991–1.026	.342
Donor BMI	1.000	0.990–1.010	.97	1.026	0.986–1.068	.211	0.998	0.982–1.014	.769
Donor COD 2 (ref 1)				1.639	0.909–2.956	.1
Donor COD 3				1.055	0.464–2.398	.898
Donor COD 4				2.322	0.491–10.985	.288
Donor HT (ref 0)				2.190	1.385–3.466	.0008
Donor DM (ref 0)				1.576	0.786–3.160	.2
CIT	1.013	0.991–1.035	.256	1.001	0.964–1.040	.962	1.274	1.041–1.560	.019
cPRA	1.000	0.994–1.006	.963	1.001	0.994–1.009	.742	0.997	0.985–1.009	.604
MM A 1 (ref 0)	0.659	0.414–1.050	.08	0.624	0.321–1.210	.163	0.683	0.353–1.323	.259
MM A 2	0.888	0.546–1.445	.632	0.991	0.515–1.910	.979	0.523	0.217–1.260	.149
MM B 1 (ref 0)	0.919	0.526–1.603	.765	0.654	0.312–1.371	.2609	1.277	0.545–2.992	.573
MM B 2	0.909	0.520–1.590	.738	0.689	0.336–1.414	.3097	1.023	0.405–2.589	.961
MM DR 1 (ref 0)	0.846	0.561–1.277	.427	1.024	0.612–1.712	.929	0.625	0.314–1.246	.182
MM DR 2	1.464	0.919–2.331	.109	2.081	1.170–3.703	.013	0.866	0.391–1.918	.722
Age difference	0.970	0.956–0.983	<.0001	0.967	0.944–0.991	.007	0.963	0.945–0.981	<.0001
UBI	0.998	0.984–1.013	.843	1.016	0.995–1.037	.139	0.977	0.958–0.997	.002
eGFR at PKT	0.995	0.951–1.041	.842	0.969	0.915–1.027	.295	1.045	0.972–1.122	.232

Significant values in bold.

COD: cause of death; HT: hypertension; DM: diabetes mellitus; MM: mismatch.

CKD baseline disease: 1, ADPKD; 2, CAKUT; 3, diabetes mellitus; 4, hypertension/RVD; 5, glomerulonephritis; 6, ‘other primary renal disease’; 7, unknown or missing.